# Implications of rituximab pharmacokinetic and pharmacodynamic alterations in various immune-mediated glomerulopathies and potential anti-CD20 therapy alternatives

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/implications-of-rituximab-pharmacokinetic-and-pharmacodynamic-alterations-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jan Miroslav Hartinger,Vojtěch Krátký,Zdenka Hrušková,Ondřej Slanař,Vladimı́r Tesař |
| Citations | 51 |
| DOI | 10.3389/fimmu.2022.1024068 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024068/pdf |
| OpenAlex ID | https://openalex.org/W4308448739 |
| PMID | 36420256 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Jan Miroslav Hartinger](https://scholariq.org/researchers/jan-miroslav-hartinger/)

## Paper journal

- [Frontiers in Immunology](https://scholariq.org/journals/frontiers-in-immunology/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.